Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

John Taylor Temporarily Replaces Sharfstein As FDA's Second-In-Command

Jan 10 2011

• By Elizabeth Crawford

Related Content

Sharfstein Takes “Acting” Title Literally, Starting FDA Overhaul

Apr 13 2009

FDA, Trade Groups Team Up To Bolster Enforcement On Tainted Supplements

Dec 20 2010

FDA Call For Pediatric Cough/Cold Input Signals New Rule Is A Long Way Off

Aug 25 2008

Additional Topics

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window